MEREO BIOPHARMA GROUP PLC (MREO) Net margin 2023–2025
MEREO BIOPHARMA GROUP PLC (MREO) net profit margin by fiscal year — reported net income divided by reported revenue.
-8375.6%FY2025 · since FY2023: -294.7% → -8375.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8375.6% | — |
| FY2023 | -294.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More MREO financial trends
MREO RevenueMREO Net incomeMREO Gross profitMREO Gross marginMREO Operating incomeMREO Operating marginMREO Operating cash flowMREO Free cash flowMREO Capital expendituresMREO Return on equityMREO Stock buybacksMREO Dividends paidMREO Total assetsMREO Total liabilitiesMREO Shareholders’ equityMREO overview →